March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of the groundbreaking ...
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the device.
Uterine Artery Embolization for Fibroids: Considerations in Patient Selection and Clinical Follow-up
Since we began performing uterine artery embolization for fibroids, we have received numerous direct inquiries from women, their husbands, and their primary care physicians. We were initially ...
Key milestones and clinical highlights of Terumo Neuro's WEB embolization system include: Unparalleled Clinical Data: The WEB device has been studied in over 600 patients across seven GCP trials ...
Key milestones and clinical highlights of Terumo Neuro's WEB embolization system include: The WEB device's continued evolution underscores Terumo Neuro's dedication to advancing neurovascular ...
Terumo Neuro Celebrates 15 Years of the WEB Device: A Game-Changing Innovation in Aneurysm Treatment
ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results